Literature DB >> 2590558

High prevalence of serum antibody against human T cell leukemia virus type I (HTLV-I) among the Bismam Asmat population (Indonesian New Guinea).

M C Re1, M Tommaseo, G Furlini, M La Placa.   

Abstract

An unusually high prevalence (45%) of serum antibodies to human T cell leukemia virus type I (or to an antigenically related virus) in comparison with that observed against other viral pathogens (human immunodeficiency virus type 1, herpes simplex virus, human cytomegalovirus, varicella zoster virus, and respiratory syncytial virus) has been observed in a group of Bismam Asmat (Papua) subjects, living in a very limited and geographically isolated area of Indonesian New Guinea.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2590558     DOI： 10.1089/aid.1989.5.551

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


  8 in total

1.  The prevalence of antibodies to human T-lymphotropic virus type I in different population groups in Papua New Guinea.

Authors:  R C Sanders; P M Wai'in; S S Alexander; A G Levin; W A Blattner; M P Alpers
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

2.  Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands.

Authors:  A Gessian; R Yanagihara; G Franchini; R M Garruto; C L Jenkins; A B Ajdukiewicz; R C Gallo; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Characterization of a variant of human T-lymphotropic virus type I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea.

Authors:  R Yanagihara; V R Nerurkar; R M Garruto; M A Miller; M E Leon-Monzon; C L Jenkins; R C Sanders; P P Liberski; M P Alpers; D C Gajdusek
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

4.  Immunologic cross-reactivity between structural proteins of human T-cell lymphotropic virus type I and the blood stage of Plasmodium falciparum.

Authors:  R B Lal; D Rudolph; M P Alpers; A J Sulzer; Y P Shi; A A Lal
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

5.  Epidemiological Aspects and World Distribution of HTLV-1 Infection.

Authors:  Antoine Gessain; Olivier Cassar
Journal:  Front Microbiol       Date:  2012-11-15       Impact factor: 5.640

6.  Geographical distribution of subjects seropositive for human T-cell leukemia virus type 1 in Papua New Guinea.

Authors:  J Imai; S Terashi; T Talonu; H Komoda; T Taufa; G T Nurse; D Babona; K Yamaguchi; H Nakashima; K Ishikawa
Journal:  Jpn J Cancer Res       Date:  1990-12

7.  Verification of HTLV-I infection in the Solomon Islands by virus isolation and gene amplification.

Authors:  R Yanagihara; A B Ajdukiewicz; V R Nerurkar; R M Garruto; D C Gajdusek
Journal:  Jpn J Cancer Res       Date:  1991-03

8.  Antibody to HTLV-I in indigenous inhabitants of the Andes and Amazon regions in Colombia.

Authors:  T Zamora; V Zaninovic; M Kajiwara; H Komoda; M Hayami; K Tajima
Journal:  Jpn J Cancer Res       Date:  1990-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.